NEFL and Alzheimer disease: Our most salient finding is that the serum NfL level is elevated in AD SCA patients and is correlated with the clinical severity markers of AD SCA such as trinucleotide repeat number, disease duration, disease duration/age × trinucleotide repeat number, and clinical severity (SARA score).